Comparative Analysis of Methadone’s Impact on Gut Microbiome: A Cross-Population Study Between the United States and China

Background: Methadone, a synthetic opioid, is frequently employed as an alternative treatment for opioid use disorder (OUD) and the management of chronic pain. However, its prolonged usage comes with a notable drawback: adverse effects on the gut microbiome. The utilization of methadone has been associated with substantial modifications in both the composition and functionality of the gut microbiome. These alterations encompass shifts in bacterial diversity and abundance, which can potentially exert significant influences on gut health and the intricate gut-brain axis. This article undertakes a meticulous examination, conducting a comparative analysis of findings from two distinct studies conducted in the United States and China. Through this approach, it sheds light on the multifaceted impact of methadone on the gut microbiome, elucidating the potential ramifications of these effects on addiction and overall health. The overarching objective is to provide readers with a comprehensive understanding of how methadone influences the gut microbiome, underscoring the imperative necessity for further exploration in this promising yet understudied realm. Methods: We obtained gut microbiome data from two sources: the study conducted by Li et al. (2020), accessible under accession number PRJEB36803, and the study by Cruz- Lebrón et al. (2021). These datasets were used to examine two distinct cohorts of individuals undergoing methadone maintenance treatment (MMT) for opioid use disorder (OUD). The first cohort included 24 patients from the Cleveland Treatment Center and Case Western Reserve University in USA. The second cohort comprised 16 MMT patients from Honghe Prefecture, Yunnan Province, China, with ages ranging from 29 to 58 years. To analyze the raw 16S rRNA amplicon sequence data, we employed the EzBioCloud metagenomics platform. Results: Both studies demonstrated that methadone use can lead to alterations in gut microbiome composition and potentially impact metabolic pathways within the gut microbiome, affecting nutrient metabolism and overall health. These alterations were observed in both American and Chinese populations, with differences in the abundance of specific bacterial taxa, including a reduction in beneficial Bacteroidetes and an increase in Firmicutes, noted in the American study compared to China MP. Conclusion: Methadone use can modulate the gut microbiome, which can have implications for addiction and health. These findings emphasize the need for further research into the relationship between methadone use, gut microbiome composition, and its implications for human health, especially in the context of different populations and their unique microbiome profiles.